Sunday, April 24, 2011

Compositions And Methods For Treatment Of Mitochondrial Diseases Patent 7915233

›
Patent 7915233, Mar.,29, 2011 In page 10 :
Thursday, April 21, 2011

An Open Label Clinical Pilot Study of Resveratrol as Treatment for Friedreich Ataxia

›
Sponsor: Murdoch Childrens Research Institute Collaborator: Friedreich Ataxia Research Alliance Principal Investigator: Martin Delatycki, ...

Excellent in-depth explanation of Friedreich Ataxia for all public

›
In the CAFA - Claude St-Jean Foundation website can find this diaporama where Dr. Jacques P. Tremblay, Ph.D., professor in the Department of...
Wednesday, April 20, 2011

Spinocerebellar degenerations.

›
Handb Clin Neurol. 2011;100:113-40. Perlman SL. Keywords: spinocerebellar ataxias (SCA), cerebellum, hyperkinetic movements, dominant at...
Tuesday, April 19, 2011

A Boolean probabilistic model of metabolic adaptation to oxygen in relation to iron homeostasis and oxidative stress

›
BMC Systems Biology 2011, 5:51doi:10.1186/1752-0509-5-51 Fiona Achcar, Jean-Michel Camadro and Denis Mestivier Interesting tool, could b...
Monday, April 18, 2011

Sirt1 acts in association with PPARĪ± to protect the heart from hypertrophy, metabolic dysregulation, and inflammation

›
Cardiovasc Res (2011) 90 (2): 276-284. doi: 10.1093/cvr/cvq376 Ana Planavila1,2,*, Roser Iglesias1,2, Marta Giralt1,2 and Francesc Villar...

Friedreich's ataxia: Past, present and future

›
doi:10.1016/j.brainresrev.2011.04.001 Daniele Marmolino, Laboratoire de Neurologie experimentale, Universite Libre de Bruxeles (ULB), Rou...
Saturday, April 16, 2011

Project title: Characterising gait and upper limb disorder in Friedreich ataxia

›
Monash University will launch a new study about Friedreich's ataxia "This project will enable both clinical and quantified gait a...

Infectious delivery and long-term persistence of transgene expression in the brain by a 135-kb iBAC-FXN genomic DNA expression vector.

›
Gene Therapy, 14 April 2011; doi:10.1038/gt.2011.45. Gimenez-Cassina A, Wade-Martins R, Gomez-Sebastian S, Corona JC, Lim F, Diaz-Nido J. ...
Tuesday, April 12, 2011

Intellect Neurosciences Files Orphan Drug Application in the United States for Its Clinical Candidate OX1 for the Treatment of Friedreich's Ataxia

›
NEW YORK, April 12, 2011 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. announced today that it has filed an orphan drug application with...